Dahai Liu
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 6
- Molecular Medicine top 10%
- Pharmaceutical Science top 10%
-
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 3
-
- Nanoplatforms for cancer theranostics 4
-
- RNA modifications and cancer 4
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Jun WangJing LiuHua YangWenxing LiJustin LiuWenjie JiaoWenhao SuYanting Dong
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Dahai Liu
44 papers receiving 636 citations
Peers
Comparison fields: 5 of 101
- Biomaterials 131
- Molecular Medicine 48
- Pharmaceutical Science 31
- Cancer Research 57
- Oncology 92
Countries citing papers authored by Dahai Liu
This map shows the geographic impact of Dahai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahai Liu more than expected).
Fields of papers citing papers by Dahai Liu
This network shows the impact of papers produced by Dahai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahai Liu. The network helps show where Dahai Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dahai Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 21 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 34 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 39 | |
| 17 | 2020 | 1 | |
| 18 | 2019 | 3 | |
| 19 | 2018 | 21 | |
| 20 | 2017 | 18 |
About Dahai Liu
Dahai Liu is a scholar working on Biomaterials, Molecular Medicine and Oncology, having authored 47 papers that have together received 653 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Lung Cancer Treatments and Mutations (5 papers), Nanoplatforms for cancer theranostics (4 papers), RNA modifications and cancer (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Biomaterials (131 citations), Molecular Medicine (48 citations) and Pharmaceutical Science (31 citations). Dahai Liu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Jun Wang, Jing Liu, Hua Yang, Wenxing Li, Justin Liu, Wenjie Jiao, Wenhao Su, Yanting Dong, Tong Lü and Yi Qin. Their work appears in journals such as Nature Communications, The EMBO Journal and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.